161 related articles for article (PubMed ID: 28378364)
1. Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.
Borup C; Wildt S; Rumessen JJ; Bouchelouche PN; Graff J; Damgaard M; McQuitty C; Rainteau D; Munck LK
Aliment Pharmacol Ther; 2017 Jun; 45(11):1433-1442. PubMed ID: 28378364
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19.
Borup C; Syversen C; Bouchelouche P; Damgaard M; Graff J; Rumessen JJ; Munck LK
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1399-402. PubMed ID: 26426834
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
Pattni SS; Brydon WG; Dew T; Johnston IM; Nolan JD; Srinivas M; Basumani P; Bardhan KD; Walters JR
Aliment Pharmacol Ther; 2013 Oct; 38(8):967-76. PubMed ID: 23981126
[TBL] [Abstract][Full Text] [Related]
4. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
[TBL] [Abstract][Full Text] [Related]
5. Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid Test.
Borup C; Wildt S; Rumessen J; Graff J; Bouchelouche PN; Andersen TB; Vinter-Jensen L; Zaremba A; German Jørgensen SP; Gregersen T; Nøjgaard C; Timm HB; Rainteau D; Gauliard E; Munck LK
Am J Gastroenterol; 2020 Dec; 115(12):2086-2094. PubMed ID: 32740083
[TBL] [Abstract][Full Text] [Related]
6. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.
Walters JR; Johnston IM; Nolan JD; Vassie C; Pruzanski ME; Shapiro DA
Aliment Pharmacol Ther; 2015 Jan; 41(1):54-64. PubMed ID: 25329562
[TBL] [Abstract][Full Text] [Related]
7. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.
Vijayvargiya P; Camilleri M; Carlson P; Lueke A; O'Neill J; Burton D; Busciglio I; Donato L
Aliment Pharmacol Ther; 2017 Sep; 46(6):581-588. PubMed ID: 28691284
[TBL] [Abstract][Full Text] [Related]
8. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
Battat R; Duijvestein M; Vande Casteele N; Singh S; Dulai PS; Valasek MA; Mimms L; McFarland J; Hester KD; Renshaw M; Jain A; Sandborn WJ; Boland BS
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2722-2730.e4. PubMed ID: 30448597
[TBL] [Abstract][Full Text] [Related]
9. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
Friedrich D; Marschall HU; Lammert F
BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
[TBL] [Abstract][Full Text] [Related]
10. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
Walters JR; Tasleem AM; Omer OS; Brydon WG; Dew T; le Roux CW
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1189-94. PubMed ID: 19426836
[TBL] [Abstract][Full Text] [Related]
11. Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.
Johnston IM; Nolan JD; Pattni SS; Appleby RN; Zhang JH; Kennie SL; Madhan GK; Jameie-Oskooei S; Pathmasrirengam S; Lin J; Hong A; Dixon PH; Williamson C; Walters JR
Am J Gastroenterol; 2016 Mar; 111(3):423-32. PubMed ID: 26856750
[TBL] [Abstract][Full Text] [Related]
12. Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose.
Zhang J; Li H; Zhou H; Fang L; Xu J; Yan H; Chen S; Song Q; Zhang Y; Xu A; Fang Q; Ye Y; Jia W
Sci Rep; 2017 Jul; 7(1):6042. PubMed ID: 28729691
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Serum and Distal Ileum Fibroblast Growth Factor19 in Bile Acid Diarrhoea Patients.
Chang C; Jiang J; Sun R; Wang S; Chen H
Dig Dis Sci; 2022 Mar; 67(3):872-879. PubMed ID: 34041651
[TBL] [Abstract][Full Text] [Related]
14. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids.
Zhang JH; Nolan JD; Kennie SL; Johnston IM; Dew T; Dixon PH; Williamson C; Walters JR
Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(10):G940-8. PubMed ID: 23518683
[TBL] [Abstract][Full Text] [Related]
15. Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.
Lyutakov I; Lozanov V; Sugareva P; Valkov H; Penchev P
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):380-387. PubMed ID: 33177381
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
Appleby RN; Moghul I; Khan S; Yee M; Manousou P; Neal TD; Walters JRF
PLoS One; 2019; 14(1):e0211348. PubMed ID: 30682184
[TBL] [Abstract][Full Text] [Related]
17. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects.
Einarsson C; Hillebrant CG; Axelson M
Hepatology; 2001 May; 33(5):1189-93. PubMed ID: 11343248
[TBL] [Abstract][Full Text] [Related]
18. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
Schreuder TC; Marsman HA; Lenicek M; van Werven JR; Nederveen AJ; Jansen PL; Schaap FG
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G440-5. PubMed ID: 20093562
[TBL] [Abstract][Full Text] [Related]
19. Chenodeoxycholic Acid Modulates Bile Acid Synthesis Independent of Fibroblast Growth Factor 19 in Primary Human Hepatocytes.
Johansson H; Søndergaard JN; Jorns C; Kutter C; Ellis ECS
Front Endocrinol (Lausanne); 2020; 11():554922. PubMed ID: 33692750
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.
Pattni SS; Brydon WG; Dew T; Walters JR
Clin Transl Gastroenterol; 2012 Jul; 3(7):e18. PubMed ID: 23238290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
